
Equity.Guru podcast: Eureka 93 (ERKA.C) provides answers on dissolved partnership and 15:1 share rollback
Eureka 93 (ERKA.C) is trying to get back on track in the wake of a dissolved partnership with Canopy Growth (WEED.T), a 15:1 share rollback
Eureka 93 (ERKA.C) is trying to get back on track in the wake of a dissolved partnership with Canopy Growth (WEED.T), a 15:1 share rollback
A JV between Acenzia, Livewell’s (LVWL.V) newly acquired subsidiary, and nutritional supplement producer PRO-DIP launched their eponymously named nutritional supplement on Amazon’s (AMZN.Q) e-commerce website today. Both
This week has been a big one in the cannabis sector. In this edition of Equity.Guru’s cannabis roundup, we’ll be covering the latest news from Livewell (LVWL.V),
On March 14, 2019 LiveWell (LVWL.C) announced that it has finalized a CBD supply agreement with Tilray (TLRY.NASDAQ). LiveWell will supply Tilray with 150 kg
I’ve not exactly been hiding my opinion that a lot of weed investments right now are overpriced market plays that, when the rubber hits the
According to data compiled by Bloomberg, in 2018 Canadian weed companies triggered $12.8 billion in takeovers & acquisitions and $4.3 billion in financings. There were
LiveWell (LVWL.V) keeps rocketing higher. LiveWell announced Dec. 19 they will acquire Acenzia, a company out of Tecumseh, Ont. Acenzia manufactures natural health products and supplements.
Livewell Canada (LVWL.V) pushes forward in its merger with Vitality CBD Natural Health Products in time to lure in cannabis giant Tilray (TLRY.Q) for a
CannaStrips, Lifestyle Delivery Systems’ (LDS.C) cannabis-infused oral strips, are at long last available for purchase in Sacramento, California. The release of CannaStrips has been five years
On December 3, 2018 LiveWell (LVWL.V) announced that it has signed a binding L.O.I to acquire 100% of Vitality CBD Natural Health Products and its
Two weeks ago, we wrote about LiveWell (LVWL.V) because we liked the company. It was trading at .67. Despite a grumpy two weeks in the
Cannabinoid (CBD) – a non-psychoactive isomer of THC – has become such a sizzling hot commodity that Chris Burggraeve, a former Coca-Cola (KO.NYSE) executive, recently